Philip Morris International highlighted strong financial performance and continued growth in its smoke-free portfolio during its 2026 Annual Meeting, reporting net revenues exceeding $40 billion in 2025, including nearly $17 billion from smoke-free products. The company said it delivered its fifth consecutive year of volume growth and remains focused on expanding its smoke-free business, which now accounts for a significant share of total revenues and is used by more than 43 million adult consumers globally.
PMI reaffirmed its outlook for continued growth through 2026–2028 and its commitment to shareholder returns, while noting ongoing investments in innovation and regulatory progress for alternative products. The company also pointed to a complex operating environment, including regulatory pressures, geopolitical risks, and shifting consumer behavior, but said its performance in early 2026 supports confidence in achieving its long-term strategy.











As part of the AGM, delegates also visited a research farm in Oxford, North Carolina, where Loren Fisher, director of N.C. State Research Stations and Field Labs, explained how the U.S. conducts tobacco production research—how it allocates financing, for example, or how it handles technical aspects related to resilient varieties. ITGA delegates agreed that this is an incredible asset for local growers—one that needs to be kept at all costs. The group also visited a field where experts was noted that crop failures are welcome in the research environment as they help in the pursuit for productivity improvements for the future.


